Piper Sandler Sticks to Their Hold Rating for Apellis Pharmaceuticals (APLS)
In a report released today, Biren Amin from Piper Sandler maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research Report), with a ...
Analysts on Trump's impact on the health care industry
Apryl Childs-Potter, president of the Nashville Health Care Council, introduces the panel at the annual Wall Street View on ...
Piper Sandler Cuts Chipotle Mexican Grill (NYSE:CMG) Price Target to $59.00
Chipotle Mexican Grill (NYSE:CMG – Free Report) had its price target trimmed by Piper Sandler from $60.00 to $59.00 in a ...
Hosted on MSN2d
Piper Sandler Upgrades Nevro (NVRO)
Fintel reports that on February 7, 2025, Piper Sandler upgraded their outlook for Nevro (NYSE:NVRO) from Underweight to ...
Tyson Foods Stock Trading Around Fair Value, Analyst Upgrades Stock To Neutral
Piper Sandler analyst Michael Lavery upgraded the shares of Tyson Foods Inc (NYSE:TSN) from Underweight to Neutral and ...
QUALCOMM (NASDAQ:QCOM) Price Target Cut to $190.00 by Analysts at Piper Sandler
QUALCOMM (NASDAQ:QCOM – Get Free Report) had its price objective decreased by investment analysts at Piper Sandler from ...
Yahoo Finance2d
Piper Sandler Offers Stockholders a New Share Buyback Program
Piper Sandler Companies PIPR has announced a new share repurchase plan. The board of directors has approved the repurchase of up to $150 million worth of shares of PIPR’s outstanding stock.
Piper Sandler Remains a Buy on Pliant Therapeutics (PLRX)
Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) today and set a price target of ...